A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy
Clinical trial NCT01209689 · TERMINATED
Trial details
- NCT number
- NCT01209689
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-12-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.